Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Not applicable

The Effect of Web-based Education on Gynecological Cancer Awareness and Healthy Life Behaviors

NCT07007975 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-05-30
Last updated
2025-06-06

Condition(s) studied

Healthy Women

Investigational drug(s) / intervention(s)

Web based training

Web based training: This group will receive information about healthy lifestyle behaviors and gynecological cancer awareness.

Study summary

There are cross-sectional or quasi-experimental studies in the literature on gynecological cancer awareness, but there are no fully experimental studies. The study we will conduct will use a control group and will be a fully experimental study. Thus, it is thought to contribute more to the field. The purpose of the study is to determine the effect of gynecological cancer education given to married women on their gynecological cancer awareness and healthy living behaviors.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Being between the ages of 20-65 * Being open to communication * Being literate * Being able to use the internet * Having a smart phone or computer Exclusion Criteria: * Being pregnant * Being breastfeeding * Not being able to use a website * Not having watched all the videos on the website * Having a history of gynecological cancer in oneself or in one's family

Primary outcome measure(s)

  • Gynecological cancer awareness scale — 4 weeks
    Preliminary test results received. The minimum score that can be obtained from the scale is 41, the maximum score is 205. The pre-training scale score average of the experimental group is 90.97.

Trial sites (1)

FacilityCityRegionStatus
Family Health Center Malatya Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07007975 on ClinicalTrials.gov ↗ ← All trials in Turkey